Published July 10, 2023 | Version v1

On the robustness of regressing tumor percentage as an explainable detector in histopathology whole-slide images

Description

Bigpicture is a public-private partnership funded by the EU Innovative Medicines Initiative (IMI) bringing together academic institutions, small- and medium-sized enterprises, public organisations, pharmaceutical companies, and a large network of partners.

This record contains the conference paper presented at the MIDL 2023 (Medical Imaging with Deep Learning) conference in Nashville, USA.

In recent years, Multiple Instance Learning (MIL) approaches have gained popularity to address the task of weakly-supervised tumor detection in whole-slide images (WSIs). However, standard MIL relies on classification methods for tumor detection that require negative control, i.e., tumor-free cases, which are challenging to obtain in real-world clinical scenarios, especially when considering surgical resection specimens. Inspired by recent work, in this paper we tackle tumor detection via a MIL-like weakly-supervised regression approach to predict the percentage of tumor present in WSIs, a clinically available target that allows to overcome the problem of need for manual annotations or presence of tumor-free slides. We characterize the quality of such a target by investigating its robustness in the presence of noise on regression percentages and provide explainability through attention maps. We test our approach on breast cancer data from primary tumor and lymph node metastases.

Files

midl-2023.pdf

Files (14.7 MB)

Name Size Download all
md5:8f4e9bd65b60509846131cc43c002d32
14.7 MB Preview Download

Additional details

Funding

European Commission
BIGPICTURE - Central Repository for Digital Pathology 945358